UK biotech raises mln from Novartis, others
Reuters
LONDON, Feb 24 (Reuters) - Heptares Therapeutics Ltd, a two-year-old British biotech company, has raised 21 million pounds (.6 million) in private equity finance from Novartis (NOVN.VX) and two venture capital firms, it said on Tuesday.
Heptares Secures GBP21 Million in Series A Fund Raising to FOXBusiness
all 15 news articles